BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 35004308)

  • 1. HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies.
    Wang X; Du ZW; Xu TM; Wang XJ; Li W; Gao JL; Li J; Zhu H
    Front Oncol; 2021; 11():785111. PubMed ID: 35004308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model.
    Gao F; Chattopadhyay A; Navab M; Grijalva V; Su F; Fogelman AM; Reddy ST; Farias-Eisner R
    J Pharmacol Exp Ther; 2012 Aug; 342(2):255-62. PubMed ID: 22537771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
    Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
    Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological and prognostic significance of hypoxia-inducible factor 1α expression in epithelial ovarian cancer: a meta-analysis.
    Jin Y; Wang H; Liang X; Ma J; Wang Y
    Tumour Biol; 2014 Aug; 35(8):8149-59. PubMed ID: 24845029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Inducible Factor-1α (HIF-1α) Promotes Hypoxia-Induced Invasion and Metastasis in Ovarian Cancer by Targeting Matrix Metallopeptidase 13 (MMP13).
    Zhang H; Yang Q; Lian X; Jiang P; Cui J
    Med Sci Monit; 2019 Sep; 25():7202-7208. PubMed ID: 31587013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
    Zhang X; Qi Z; Yin H; Yang G
    Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS; Simons JW
    Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
    Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
    Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma.
    Deng Z; Teng YJ; Zhou Q; Ouyang ZG; Hu YX; Long HP; Hu MJ; Mei S; Lin FX; Dai XJ; Zhang BY; Feng T; Tian XF
    World J Gastrointest Oncol; 2021 Nov; 13(11):1725-1740. PubMed ID: 34853646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1α nuclear translocation and its target gene activation against neoplastic progression.
    Thirusangu P; Vigneshwaran V; Ranganatha VL; Vijay Avin BR; Khanum SA; Mahmood R; Jayashree K; Prabhakar BT
    Biochem Pharmacol; 2017 Feb; 125():26-40. PubMed ID: 27838496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions.
    Duan L; Tao J; Yang X; Ye L; Wu Y; He Q; Duan Y; Chen L; Zhu J
    J Ovarian Res; 2020 Apr; 13(1):40. PubMed ID: 32312328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scutellaria baicalensis targets the hypoxia-inducible factor-1α and enhances cisplatin efficacy in ovarian cancer.
    Hussain I; Waheed S; Ahmad KA; Pirog JE; Syed V
    J Cell Biochem; 2018 Sep; 119(9):7515-7524. PubMed ID: 29797601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
    He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
    Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia.
    Zhu P; Ning Y; Yao L; Chen M; Xu C
    J Exp Clin Cancer Res; 2010 Sep; 29(1):124. PubMed ID: 20831794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors.
    Rehman Z; Fahim A; Bhatti A; Sadia H; John P
    PeerJ; 2019; 7():e6309. PubMed ID: 30746305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.
    Huang L; Ao Q; Zhang Q; Yang X; Xing H; Li F; Chen G; Zhou J; Wang S; Xu G; Meng L; Lu Y; Ma D
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):447-56. PubMed ID: 19760195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; Turley H; Harris AL; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2005 Nov; 93(10):1128-36. PubMed ID: 16251878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
    Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
    Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
    Li J; Xi W; Li X; Sun H; Li Y
    Bioorg Med Chem; 2019 Apr; 27(7):1145-1158. PubMed ID: 30819620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.